Alzheimer's disease (AD) is characterised by the presence of intracellular neurofibrillary tangles (NFTs), neurofibrillary threads, extracellular amyloid plaques and accumulation of amyloid in cerebral blood vessels. The major component of the amyloid is a 39-43 amino acids peptide calledamyloid (A ). A derives from the amyloid precursor protein (APP), which is a widely expressed transmembrane protein [1]. Although the function of APP is not known, it has been proposed to have a role in regulation of neurite extension, synapse formation, neuronal development and neuroprotection [2][3][4].A is produced from APP via proteolytic cleavage by proteases called -and -secretase.
Abstract-amyloid (A ) is the main constituent of senile plaques seen in Alzheimer's disease. A is derived from the amyloid precursor protein (APP) via proteolytic cleavage by proteases -and -secretase. In this study, we examined content and localization of -secretase-cleaved APP ( -sAPP) in brain tissue sections from the frontal, temporal and occipital lobe. Strong granular -sAPP staining was found throughout the gray matter of all three areas, while white matter staining was considerably weaker. -sAPP was found to be localized in astrocytes and in axons. We found the -sAPP immunostaining to be stronger and more extensive in gray matter in Alzheimer disease (AD) cases than controls. The axonal -sAPP staining was patchy and unevenly distributed for the AD cases, indicating impaired axonal transport. -sAPP was also found surrounding senile plaques and cerebral blood vessels. The results presented here show altered -sAPP staining in the AD brain, suggestive of abnormal processing and transport of APP.